These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15814088)

  • 1. Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
    Wu CC; Chen JY; Tao PL; Chen YA; Yeh GC
    Eur J Pharmacol; 2005 Apr; 512(1):37-42. PubMed ID: 15814088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
    Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL
    Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
    Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
    Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways.
    Singh VP; Jain NK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2003 May; 25(4):273-80. PubMed ID: 12808472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine attenuated morphine withdrawal syndrome in the rat.
    Charkhpour M; Jafari RM; Ghavimi H; Ghanbarzadeh S; Parvizpur A
    Drug Res (Stuttg); 2014 Aug; 64(8):393-8. PubMed ID: 24265113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
    Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
    Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythm influences naloxone induced morphine withdrawal and neuronal activity of lateral paragigantocellularis nucleus.
    Rahmati-Dehkordi F; Ghaemi-Jandabi M; Garmabi B; Semnanian S; Azizi H
    Behav Brain Res; 2021 Sep; 414():113450. PubMed ID: 34265318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal].
    Cao JL; Ding HL; He JH; Zhang LC; Wang JK; Zeng YM
    Sheng Li Xue Bao; 2005 Apr; 57(2):161-8. PubMed ID: 15830100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
    Caillé S; Espejo EF; Koob GF; Stinus L
    Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activation of the spinal extracellular signal-regulated kinase is involved in morphine dependence and naloxone-precipitated withdrawal response].
    He JH; Cao JL; Xu YB; Song XS; Ding HL; Zeng YM
    Sheng Li Xue Bao; 2005 Oct; 57(5):557-65. PubMed ID: 16220193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
    Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
    Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect serotonergic agonists attenuate neuronal opiate withdrawal.
    Akaoka H; Aston-Jones G
    Neuroscience; 1993 Jun; 54(3):561-5. PubMed ID: 8332249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking naloxone-precipitated withdrawal in rats and hamsters.
    Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
    Alcaraz C; Vargas ML; Milanés MV
    Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
    Cao JL; Liu HL; Wang JK; Zeng YM
    Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
    Lu L; Su WJ; Yue W; Ge X; Su F; Pei G; Ma L
    Life Sci; 2001 May; 69(1):37-46. PubMed ID: 11411809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.